- Home
- united kingdom
- Companies
Refine by
Medical Industry Technology In United Kingdom
31 companies found
Technologybased inCambridge, UNITED KINGDOM
Nuclera is the pioneer in bringing rapid protein prototyping to the benchtop. We make proteins accessible through eProtein DiscoveryTM. Through our technology, we accelerate breakthrough improvements in human health and empower life science ...
Technologybased inFairfield, CONNECTICUT (USA)
GE is Imagination at work. From jet engines to power generation, financial services to water processing, and medical imaging to media content, GE people worldwide are dedicated to turning imaginative ideas into leading products and services that ...
Technologybased inCambridge, UNITED KINGDOM
Lightcast is developing a cell manipulation platform that utilises tiny spots of light to control thousands of cells and reagents at once, enabling game-changing workflows for the pharmaceutical industry. With applications ranging from ...
Technologybased inSt. Louis, MISSOURI (USA)
Emerson has boldly transformed to create value for our customers and shareholders. With our newly energized focus on our two core business platforms — Automation Solutions and Commercial & Residential Solutions — we can confront the challenges of an ...
Technologybased inEpsom, UNITED KINGDOM
Our goal is to transform animal health through data intelligence. We will create the first integrated biomarker, health microchip and activity monitor for pets and livestock, for real time remote health monitoring, early detection of disease, ...
Chordata Ora for pets, Chordata Dairy and Chordata Beef, biomarker chips conform to global safety standards and local data regulations. They are implanted by qualified veterinarians under the skin to measure status up to eight times daily ...
Technologybased inAbingdon, UNITED KINGDOM
Thermally Stable Needle Free Solid Dose Vaccines. Enesi Pharma is developing next-generation vaccination products targeting infectious diseases and emergent threat pathogens enabled by its ImplaVax technologies. These diseases affect millions of ...
The COVID-19 global health emergency has highlighted the need for vaccines to address novel infections, as its rapid spread has made vaccine development an urgent worldwide priority. While speed is of the essence, both scientific considerations for ...
Technologybased inBirmingham, UNITED KINGDOM
Our experienced board and management team guides Linear Diagnostics to maximise the opportunites that are emerging within the healthcare and diagnostic markets. The company’s board and management team comprises experienced medical diagnostics ...
Initially focused on sexually transmitted infections, the technology can be utilised in a wide range of diagnostic applications. Based on market opportunity, Linear Diagnostics concluded that a dual test for Chlamydia trachomatis and Neisseria ...
Technologybased inChester, UNITED KINGDOM
Byotrol's first antimicrobial technology was invented over 20 years ago, and since then we have developed a number of biocidal technologies and antimicrobial test methods, which challenge traditional disinfectant products and methods of cleaning, to ...
Technologybased inExeter, UNITED KINGDOM
Attomarker is a British company focused on nanophotonic biochemical testing. It was founded in 2008, and spun out from Professor Andrew Shaw’s research group at the University of Exeter. It has won numerous prestigious awards for innovation and been ...
Attomarker has developed a technology platform that will measure the concentration of biomarkers in blood samples, but it can be readily extended to saliva or even cerebral spinal fluid. The blood contains many components – biomarkers – ...
Technologybased inSanta Clara, CALIFORNIA (USA)
SI-BONE was founded in April 2008, as a spin out when Wright Medical bought INBONE Technologies. INBONE, with the ENDO-FUSETM Intra-Osseous Fusion System, was founded by Dr. Mark Reiley, the inventor of kyphoplasty and the vertebral fracture ...
For most of the 20th century, doctors were not focused on the SI joint as a source of chronic lower back pain, so misdiagnosis was – and can still be – common. Know what to share with your doctor and choose a doctor trained in SI joint ...
Technologybased inClydach, UNITED KINGDOM
Our cutting-edge technology is transforming the market with the incredible potential of microalgae, offering sustainable and eco-friendly solutions for a brighter future. At API, we have mastered the art of separating algae and harnessing its full ...
Discover Beta-Carotene, a natural pigment and carotenoid compound sourced from a diverse range of microalgae. Renowned for its vibrant orange or red hues, Beta-Carotene holds remarkable significance. As a precursor to vitamin A, this provitamin A ...
Technologybased inOxford, UNITED KINGDOM
Orthonika is a spin-out company from Imperial College London. It is the result of a collaboration between Imperial College and Sierra MedTech and aims to develop and commercialise a novel anatomical Total Meniscus Replacement. We are combining world ...
Orthonika's Total Meniscus Replacement is based on a unique design and proprietary high strength polymers and constructions which replicates not only the bulk macroscopic geometry of the meniscus, but also the underlying microstructure and ...
Technologybased inOxford, UNITED KINGDOM
Vaccitech is a clinical stage T cell immunotherapy and vaccine company developing products to treat and prevent infectious disease and cancer. The company’s proprietary heterologous prime-boost platform comprises Chimpanzee Adenovirus Oxford ...
The patented Vaccitech adenovirus vectors are known as chimpanzee adenovirus Oxford 1 and 2 (ChAdOx1 and ChAdOx2), and are in the group E simian adenovirus family, similar to the widely-studied chimpanzee adenovirus 63. These viruses have been ...
Technologybased inCheshire, UNITED KINGDOM
Founded in 2012 at University of Manchester, Gelmetix is a UK medtech company focused on treating chronic lower back pain caused by the degeneration of the intervertebral discs. Gelmetix’s polymer gel technology also has the potential to be adapted ...
A focus on low-back pain. About 40% of chronic low-back pain is the result of degenerative disc disease3. Gelmetix’s double cross-linked microgel (DXM) is a biological solution that addresses the source of pain. In the intervertebral disc it ...
Technologybased inCambridge, UNITED KINGDOM
GW is the global leader in developing cannabinoid-based medicines. GW has been researching cannabinoids since 1998 and has established a world leading position in the development of plant-derived cannabinoid therapeutics. GW has established a world ...
GW is committed to developing new medicines to treat rare, treatment-resistant epilepsy conditions where there are limited or in some cases, no approved treatment ...
Technologybased inNorwich, UNITED KINGDOM
We are a passionate and skilled drug discovery and development biotech team developing an innovative new class of oligonucleotide antimicrobial agents. Procarta is currently working on lead optimisation for its first product, a narrow-spectrum agent ...
Proprietary nanoparticles deliver an oligonucleotide inside the bacterial pathogen. The oligonucleotide acts as a Transcription Factor Decoy (TFD): it contains the binding site of a transcription factor that controls a large set of genes required ...
Technologybased inLeicester, UNITED KINGDOM
Freedom Hygiene is a technology driven company whose mission is to seek out innovative solutions that enable manufacturers and processors to reduce bacterial contamination in their facilities, extend production runs and, where applicable, prolong ...
Technologybased inCambridge, UNITED KINGDOM
Founded by Dr Mark Kotter and Florian Schuster, bit.bio is an award-winning human synthetic biology enterprise. bit.bio™s mission is coding cells for health. To do so, we apply the principles of computation to biology. Our current focus is to ...
Technologybased inEdinburgh, UNITED KINGDOM
Edinburgh Molecular Imaging is a clinical phase biotechnology company focused on enabling image guided interventional medicine. The company´s molecular targetting technology has the potential to tackle disease in real-time to allow interventional ...
Technologybased inCambridge, UNITED KINGDOM
Based in Cambridge, one of Europe's largest bioscience hubs, Biorbyt has a simple yet challenging mission: to provide the best service to the global scientific community. We achieve this by collaborating with the world’s finest researchers and ...
Monoclonal antibodies; one of the most widely used tools in biological research, with the potential soon to become important therapeutics, have been with us for just over 40 years. These antibodies are monovalent, bind to a single epitope and are ...
